Show simple item record

Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection

dc.contributor.authorCaptur, Gen_US
dc.contributor.authorMoon, JCen_US
dc.contributor.authorTopriceanu, C-Cen_US
dc.contributor.authorJoy, Gen_US
dc.contributor.authorSwadling, Len_US
dc.contributor.authorHallqvist, Jen_US
dc.contributor.authorDoykov, Ien_US
dc.contributor.authorPatel, Nen_US
dc.contributor.authorSpiewak, Jen_US
dc.contributor.authorBaldwin, Ten_US
dc.contributor.authorHamblin, Men_US
dc.contributor.authorMenacho, Ken_US
dc.contributor.authorFontana, Men_US
dc.contributor.authorTreibel, TAen_US
dc.contributor.authorManisty, Cen_US
dc.contributor.authorO'Brien, Ben_US
dc.contributor.authorGibbons, JMen_US
dc.contributor.authorPade, Cen_US
dc.contributor.authorBrooks, Ten_US
dc.contributor.authorAltmann, DMen_US
dc.contributor.authorBoyton, RJen_US
dc.contributor.authorMcKnight, Aen_US
dc.contributor.authorMaini, MKen_US
dc.contributor.authorNoursadeghi, Men_US
dc.contributor.authorMills, Ken_US
dc.contributor.authorHeywood, WEen_US
dc.date.accessioned2023-05-16T12:39:10Z
dc.date.available2022-09-16en_US
dc.date.issued2022en_US
dc.identifier.issn2352-3964en_US
dc.identifier.otherARTN 104293
dc.identifier.otherARTN 104293
dc.identifier.otherARTN 104293en_US
dc.identifier.otherARTN 104293en_US
dc.identifier.urihttps://qmro.qmul.ac.uk/xmlui/handle/123456789/87278
dc.relation.ispartofEBIOMEDICINEen_US
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/us/*
dc.subjectCOVID-19en_US
dc.subjectProteomicsen_US
dc.subjectPost-acute sequelae of SARS-CoV-2 (PASC)en_US
dc.titlePlasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infectionen_US
dc.typeArticle
dc.identifier.doi10.1016/j.ebiom.2022.104293en_US
pubs.author-urlhttps://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000892269200004&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6aen_US
pubs.notesNot knownen_US
pubs.publication-statusPublisheden_US
pubs.volume85en_US
qmul.funderThe Durability of immune Responses to vaccination against SARS-CoV-2 and its Variants.::Medical Research Councilen_US


Files in this item

Thumbnail
Name:
license_rdf
Size:
811bytes
Format:
application/rdf+xml
View/Open
Thumbnail
Name:
Gibbons Plasma proteomic signature ...
Size:
2.776Mb
Format:
application/
Description:
Published version
View/Open

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 United States
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 United States